Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry
- 25 August 2009
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 34 (5) , 446-450
- https://doi.org/10.1016/j.ijantimicag.2009.06.025
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and OncologyHaematologica, 2009
- Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)Clinical Infectious Diseases, 2007
- Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with NeutropeniaNew England Journal of Medicine, 2007
- Invasive AspergillosisDrugs, 2007
- Pharmacokinetic Evaluation of the Drug Interaction between Intravenous Itraconazole and Intravenous Tacrolimus or Intravenous Cyclosporin A in Allogeneic Hematopoietic Stem Cell Transplant RecipientsTransplantation and Cellular Therapy, 2006
- Itraconazole-Related Increased Vincristine NeurotoxicityJournal of Pediatric Hematology/Oncology, 2005
- Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and NeutropeniaNew England Journal of Medicine, 2004
- Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant centerTransplantation and Cellular Therapy, 2004
- Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplantsBlood, 2004
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992